Anti-idiotype induction therapy: Anti-CA125 antibodies (Ab3) mediated tumor killing in patients treated with Ovarex mAb B43.13 (Ab1)

Cancer Immunology Immunotherapy

Volumn 46, Issue 4, 1998, Pages 201-212

  Schultes, Birgit C ^a   Baum, Richard P ^b   Niesen, Andreas ^b   Noujaim, Antoine A ^a   Madiyalakan, Ragupathy ^a  

^a AltaRex Inc   (Canada)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

ADCC; Anti CA125 antibody; Anti idiotypic network; Immune histochemistry; Immunotherapy; mAb B43.13

Indexed keywords

CA 125 ANTIGEN; IMMUNOGLOBULIN IDIOTYPE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY B 43 13; UNCLASSIFIED DRUG;

ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; BINDING AFFINITY; CELL KILLING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; CA-125 ANTIGEN; FEMALE; HUMANS; MICE; MICE, INBRED BALB C; OVARIAN NEOPLASMS; RABBITS; TUMOR CELLS, CULTURED;

EID: 0031747870     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050479     Document Type: Article

References (53)

1. Adams DO, Hall T, Steplewski Z, Koprowski H (1984) Tumor undergoing rejection induced by monoclonal antibodies of the IgG2a Isotype containing increased numbers of macrophages activated for distinctive form of antibody dependent cytolysis. Proc Natl Acad Sci USA 81:3506
2. Baum RP, Noujaim AA, Nanci A, Moebus V, Hertel A, Niesen A, Donnerstag B, Sykes T, Boniface G, Hör G (1993) Clinical course of ovarian cancer patients under repeated stimulation of HAMA using mAb OC125 and B43.13. Hybridoma 12:583
3. Baum RP, Niesen A, Hertel A, Nanci A, Hess H, Donnerstag B, Sykes TR, Sykes CJ, Suresh MR, Noujaim AA, Hör G (1994) Activating anti-idiotypic human anti-mouse antibodies for immunotherapy of ovarian cancer. Cancer 73:1121
4. Bhattacharya-Chatterjee M, Mukerjee S, Biddle W, Foon KA, Köhler H (1990) Murine monoclonal anti-idiotype antibody as a potential network antigen for human carcinoembryonic antigen. J Immunol 145:2758
5. Bhattercharya-Chatterjee M, Foon KA, Kohler H (1994) Idiotype antibody immunotherapy of cancer (review). Cancer Immunol Immunother 38:75
6. Celis E, Chang TW (1984) Antibodies to hepatitis B surface antigen potentiate the response of human T lymphocyte clones to the same antigen. Science 224:297
7. Chakraborty M, Mukerjee S, Foon KA, Köhler H, Ceriani RL, Bhattacharya-Chatterjee M (1995) Induction of human breast cancer-specific antibody responses in cynomolgus monkeys by a murine monoclonal anti-idiotype antibody. Cancer Res 55:1525
8. Chattopadhyay P, Starkey J, Morrow WJ, Raychaudhuri S (1992) Murine monoclonal anti-idiotype antibody breaks unresponsiveness and induces a specific antibody response to human melanoma-associated proteoglucan antigen in cynomolgus monkeys. Proc Natl Acad Sci USA 89:2684
9. Chestnut R, Grey HM (1981) Studies on the capacity of B cells to serve as antigen-presenting cells. J Immunol 126:1075
10. Cheung NKV, Lazarus H, Miraldi FD, Abramowsky CR, Kallick S, Saarinen UM, Spitzer T, Stransjord SE, Coccia PF, Berger NA (1987) Ganglioside GD2 specific monoclonal antibody 3F8: a phase I study in patients with neuroblastoma and malignant melanoma. J Clin Oncol 5:1430
11. Durrant LG, Demon GWL, Jacobs E, Mee M, Moss R, Austin EB, Baldwin RW, Hardcastle JD, Robins RA (1992) An idiotypic replica of carcinoembryonic antigen inducing cellular and humoral responses directed against human colorectal tumours. Int J Cancer 50:811
12. Fagerberg J, Frödin J-E, Wigzell H, Mellstedt H (1993) Induction of an immune network cascade in cancer patients treated with monoclonal antibodies (ab1). I. May induction of ab1-reactive T cells and anti-anti-idiotypic antibodies (ab3) lead to tumor regression after mAb therapy? Cancer Immunol Immunother 37:264
13. Fagerberg J, Frödin J-E, Ragnhammar P, Steinitz M, Wigzell H, Mellstedt H (1994) Induction of an immune network cascade in cancer patients treated with monoclonal antibodies (ab1). II. Is induction of anti-idiotype reactive T cells (T3) of importance for tumor response to mAb therapy? Cancer Immunol Immunother 38:149
14. Fagerberg J, Hjelm AL, Ragnhammer P, Frödin JE, Wigzell H, Mellstedt H (1995) Tumor regression in monoclonal antibody-treated patients correlates with the presence of anti-idiotype-reactive T lymphocytes. Cancer Res 55:1824
15. Ferrone S (1993) Human tumor-associated antigen mimicry by anti-idiotypic antibodies, immunogenicity and clinical trials in patients with solid tumors. Ann NY Acad Sci 690:214
16. Frödin J-E, Faxas M-E, Hagström B, Lefvert A-K, Masucci G, Nilsson B, Steinitz, M, Unger P, Mellstedt H (1991) Induction of anti-idiotypic (ab2) and anti-anti-idiotypic (ab3) antibodies in patients treated with the mouse monoclonal antibody 17-1A (ab1). Relation to the clinical outcome - an important antitumoral effector function? Hybridoma 10:421
17. Herlyn, DM, Koprowski H (1981) Monoclonal anticolon carcinoma antibodies in complement-dependent cytotoxicity. Int J Cancer 27:769
18. Herlyn D, Ross AH and Koprowski H (1986) Anti-idiotypic antibodies bear the internal image of a human tumor antigen. Science 232:1300
19. Herlyn D, Ross AH, Iliopoulos D, Koprowski H (1987) Induction of specific immunity to human colon carcinoma by anti-idiotypic antibodies to monoclonal antibody CO17-1A. Eur J Immunol 17:1649
20. Houghton AN, Mintzner D, Cordon-Cardo C, Welt S, Fliegel F, Vadham S, Carswell E, Melamed MR, Oettgen HF, Old LY (1985) Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: a phase I trial in patients with malignant melanoma. Proc Natl Acad Sci USA 82:1242
21. Irie RF, Morton DL (1986) Regression of cutaneous metastatic melanoma by intralesional injection with human monoclonal antibody to ganglioside GD2. Proc Natl Acad Sci USA 83:8694
22. Jerne NK (1974) Towards a network theory of the immune system. Ann Inst Pasteur 125C:373
23. Kennedy RC, Dreesman GR (1984) Enhancement of the immune response to hepatitis B surface antigen: in vivo administration of anti-idiotype induces anti-HBS that expresses a similar epitope. J Exp Med 159:655
24. Kosmas C, Epenetos AA, Courtenay-Luck NS (1994) Activation of cellular immunity after intracavitary monoclonal antibody therapy of ovarian cancer. Cancer 73:3000
25. Krantz MJ, MacLean G, Longenecker BM, Suresh MR (1988) A radioimmunoassay for CA125 employing two new monoclonal antibodies. J Cell Biochem Suppl 12E:139
26. Lanzavecchia A (1985) Antigen-specific interactions between T and B cells. Nature 314:537
27. Lanzavecchia A, Abrignani S, Scheidegger D, Obrist R, Dörken B, Moldenhauer G (1988) Antibodies as antigens. The use of mouse monoclonal antibodies to focus human T cells against selected targets. J Exp Med 167:345
28. LoBuglio AF, Saleh MN, Lee J, Khazaeci MB, Carrano R, Holden H, Wheeler RH (1988) Phase I trial of multiple large doses of murine monoclonal antibody CA17-1A. Clinical Aspects. J Natl Cancer Inst 80:932
29. Luo D, Geng M, Noujaim AA, Madiyalakan R (1997) An engineered bivalent single-chain antibody fragment that increases antigen binding activity. J Biochem (Tokyo) 121:831
30. Madiyalakan R, Sykes TR, Dharampaul S, Sykes CJ, Baum RP, Hör G, Noujaim AA (1995) Anti-idiotype induction therapy: evidence for the induction of immune response through the idiotypic network in patients with ovarian cancer after administration of anti-CA125 murine monoclonal antibody B43.13. Hybridoma 14:199
31. Madiyalakan R, Yang R, Schultes BC, Baum RP, Noujaim AA (1997) Ovarex mAb B43.13: IFN-γ could improve the ovarian tumor cell sensitivity to CA125-specific allogenic cytotoxic T cells. Hybridoma 16:41
32. Manca F, Fenoglio D, Kunkl A, Cambiaggi C, Sasso M, Celada F (1988) Differential activation of T cell clones stimulated by macrophages exposed to antigen complexed with monoclonal antibodies. J Immunol 140:2893
33. Manca F, Fenoglio D, Pira GL, Kunkl A, Celada F (1991) Effect of antigen/antibody ratio on macrophage uptake, processing, and presentation to T Cells of antigen complexed with polyclonal antibodies. J Exp Med 173:37
34. Marusic-Galesic S, Marusic M, Pokric B (1992) Cellular immune response to the antigen administered as an immune complex in vivo. Immunology 75:325
35. Mellstedt H, Frödin JE, Masucci G, Ragnhammer P, Fagerberg J, Hjelm AL, Shetye J, Wersäll P, Österborg A (1991) The therapeutic use of monoclonal antibodies in colorectal carcinoma. Semin Oncol 18:462
36. Mittelman A, Chen ZJ, Yang H, Wong G, Ferrone S (1992) Human high molecular weight melanoma-associated antigen (HMW-MAA) mimicry by mouse anti-idiotype monoclonal antibody MK2-23: induction of humoral anti-HMW-MAA immunity and prolongation of survival in patients with stage IV melanoma. Proc Natl Acad Sci USA 89:466
37. Noujaim AA, Baum RP, Sykes TR, Madiyalakan R, Sykes CJ, Hertel A, Niesen A, Hör G (1994) Monoclonal antibody B43.13 for immunoscintigraphy and immunotherapy of ovarian cancer: In: Klapdor R (ed) Current tumor diagnosis: applications, clinical relevance, trends. Zuckschwerdt, München, p 823
38. Ortaldo JR, Woodhouse C, Morgan AC, Herberman RB, Cheresh DA, Reisfeld R (1987) Analysis of effector cells in human antibody-dependent cellular cytotoxicity with murine monoclonal antibodies. J Immunol 138:3566
39. Pervin S, Chakraborty M, Bhattacharya-Chatterjee M, Zeytin H, Foon KA, Chatterjee S (1997) Induction of antitumor immunity by an anti-idiotype antibody mimicking carcinoembryonic antigen. Cancer Res 57:728
40. Pohl C, Renner C, Schwonzen M, Schobert I, Liebenberg V, Jung W, Wolf J, Pfreundschuh M, Diehl V (1993) CD30-specific Ab1-Ab2-Ab3 internal image antibody network: potential use as anti-idiotypic vaccine against Hodgkin's lymphoma. Int J Cancer 54:418
41. Schlebusch H, Wagner U, Grünn U, Schultes B (1995) A monoclonal antiidiotypic antibody ACA 125 mimicking the tumor-associated antigen CA 125 for immunotherapy of ovarian cancer. Hybridoma 14:167
42. Schmitt H, Khazaeli MB, Rodenburg CM, Kaul S, Bastert G (1994) Production of mouse monoclonal anti-idiotypic antibodies specific to epitopes of tumor-associated mucin TAG-12. Hybridoma 13:389
43. Schultes BC, Reinsberg J, Schlebusch H, Oehr P, Biersack HJ, Krebs D, Wagner U (1993) Idiotypic cascades after injection of the monoclonal antibody OC125: a study in a mouse model. Eur J Clin Chem Clin Biochem 31:427
44. Schultes BC, Qi W, Yang R, Kuzma M, Liu D, Noujaim AA, Madiyalakan R (1997) CA125 mimicking anti-idiotypic antibody mAb-BR11.1 elicits humoral and cellular response specific for the nominal antigen. Tumor Biol 18 S2:16
45. Sears HF, Atkinson B, Mattis J, Ernst C, Herlyn D, Steplewski Z, Häyry P, Koprowski H (1982) Phase-I clinical trial of monoclonal antibody in treatment of gastrointestinal tumours. Lancet 1:762
46. Somasundaram R, Zaloudik J, Jacob L, Benden A, Sperlagh M, Hart E, Marks G, Kana M, Mastrangelo M, Herlyn D (1995) Induction of antigen-specific T and B cell immunity in colon cancer carcinoma patients by anti-idiotypic antibody. J Immunol 155:325
47. Sykes TR, Woo TK, Baum RP, Qi P, Noujaim AA (1995) Direct labeling of monoclonal antibodies with technetium-99m by photoactivation. J Nucl Med 36:1913
48. Trauth BC, Klas C, Peters AMJ, Matzku S, Möller P, Falk W, Debatin KM, Krammer PH (1989) Monoclonal Antibody mediated tumor regression by induction of apoptosis. Science 245:301
49. Wagner U (1993) Antitumor antibodies for immunotherapy of ovarian carcinomas. Hybridoma 12:521
50. Wagner U, Reinsberg J, Oehr P, Briele B, Schmidt S, Werner A, Krebs D, Biersack H-J (1990) Clinical courses of patients with ovarian carcinomas after induction of anti-idiotypic antibodies against a tumor-associated antigen. Tumordiagn Ther 11:1
51. Warren RQ, Tsang KY (1990) Induction of immunity to a human osteosarcoma-associated antigen in mice using anti-idiotypic antibodies. Clin Immunol Immunopathol 56:334
52. Wiermsa EJ (1992) Enhancement of the antibody response to protein antigens by specific IgG under different experimental conditions. Scand J Immunol 36:193
53. Zwicky C, Stahel RA, Jaksche H, Waibel R, Lehmann HP, Loibner H (1991) Polyclonal anti-idiotypic antibodies mimicking the small cell lung carcinoma antigen cluster-5A interact with a panel of antibodies and induce specific immune response in animals. Br J Cancer 14:67